Posts tagged Andrew Patient
Merus Labs appoints two senior executives

Merus Labs International (NASDAQ:MSLI; TSX:MSL) has appointed two key additions to its executive leadership team, effective July 1.

Dr. Michael Bumby was named CFO, succeeding Andrew Patient, who has decided to leave the company to pursue other opportunities. Mr. Patient will remain with Merus Labs for a period of time to ensure a smooth transition.

Read More